Inhibitory effects of Bifidobacterium longum on experimental ulcerative colitis induced in mice by synthetic dextran sulfate sodium

被引:19
作者
Fujiwara, M
Kaneko, T
Iwana, H
Taketomo, N
Tsunoo, H
Kanno, J
Ohkusa, T
Okayasu, I
机构
[1] Kitasato Univ, Sch Med, Dept Pathol, Kanagawa 2288555, Japan
[2] Japanese Red Cross Med Ctr, Dept Clin Pathol, Shibuya Ku, Tokyo, Japan
[3] Meiji Milk Prod Co Ltd, Cent Res Inst, Higashimurayama, Japan
[4] Nalt Inst Hlth & Sci, Cellular & Mol Toxicol Div, Setagaya Ku, Tokyo, Japan
[5] Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 113, Japan
[6] Meiji Milk Prod Co Ltd, Ctr Hlth Sci, Odawara, Kanagawa, Japan
关键词
ulcerative colitis; Bifidobacterium longum; intestinal flora; dextran sulfate sodium;
D O I
10.1159/000069704
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The relationship between alterations in intestinal microflora and ulcerative colitis is still not clear. Whether improvement in bacterial populations might be a new strategy for prevention or treatment needs to be tested. Methods: Ulcerative colitis was induced in mice by oral administration of synthetic dextran sulfate sodium (molecular weight 54,000). Inhibitory effects of concomitant treatment with Bifidobacterium longum were assessed in terms of total colon length and severity of histological changes. In addition, changes of microflora and short-chain fatty acids were tested in fecal samples and compared before and after treatment. Results: Administration of B. longum significantly inhibited both shortening of total colon length and the severity of ulcerative colitis compared to controls. It was confirmed that the administered B. longum resided in the gut and blocked the decrease of lactobacilli in fecal samples in mice with dextran sulfate sodium-induced colitis. Conclusions: Oral administration of B. longum exerts marked inhibitory effects on ulcerative colitis in mice. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 25 条
[1]   Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice [J].
Arai, Y ;
Takanashi, H ;
Kitagawa, H ;
Okayasu, I .
CYTOKINE, 1998, 10 (11) :890-896
[2]   Effect of Icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice [J].
Arai, Y ;
Takanashi, H ;
Kitagawa, H ;
Wirth, KJ ;
Okayasu, I .
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (04) :845-851
[3]  
Ariake Koichiro, 2000, Journal of Medical and Dental Sciences, V47, P233
[4]  
BENNO Y, 1983, SAISHIN IGAKU, V38, P1476
[5]  
COOPER HS, 1993, LAB INVEST, V69, P238
[6]   PROPHYLACTIC AND THERAPEUTIC ASPECTS OF FERMENTED MILK [J].
HITCHINS, AD ;
MCDONOUGH, FE .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 49 (04) :675-684
[7]   GROWTH STIMULATOR FOR BIFIDOBACTERIA PRODUCED BY PROPIONIBACTERIUM-FREUDENREICHII AND SEVERAL INTESTINAL BACTERIA [J].
KANEKO, T ;
MORI, H ;
IWATA, M ;
MEGURO, S .
JOURNAL OF DAIRY SCIENCE, 1994, 77 (02) :393-404
[8]   Fecal microflora in a patient with short-bowel syndrome and identification of dominant lactobacilli [J].
Kaneko, T ;
Bando, Y ;
Kurihara, H ;
Satomi, K ;
Nonoyama, K ;
Matsuura, N .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3181-3185
[9]  
Kim YI, 1998, NUTR REV, V56, P17
[10]   Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis [J].
Mähler, M ;
Bristol, IJ ;
Leiter, EH ;
Workman, AE ;
Birkenmeier, EH ;
Elson, CO ;
Sundberg, JP .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1998, 274 (03) :G544-G551